Squarepoint Ops LLC Instil Bio, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.51 - $0.67 $81,568 - $107,159	159,939 Added 256.59%	222,272 $122,000
Q1 2023 May 15, 2023	SELL	$0.6 - $0.91 $300,237 - $455,359	-500,395 Reduced 88.92%	62,333 $41,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $5.33 $270,109 - $3 Million	562,728 New	562,728 $354,000
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $70,850 - $187,643	16,829 New	16,829 $78,000
Q2 2021 Aug 16, 2021	SELL	$15.31 - $24.63 $146,486 - $235,659	-9,568 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $231,832 - $258,910	9,568 New	9,568 $240,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.84B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.